Melatonin Attenuates PFOS ‐Induced Reproductive Toxicity of Pregnant Mice due to Placental Damage Via Antioxidant, Anti‐Aging and Anti‐Inflammatory Pathways
Birth Defects Research · 2024
DOI: 10.1002/bdr2.2423 ↗At a glance
Journal article in Birth Defects Research, 2024. Written by Jianqiu Han and 7 co-authors. Institution: College of Ecological Technology and Engineering, Shanghai Institute of Technology, Shanghai, China. Major MEDLINE topics: Fluorocarbons, Melatonin, Placenta, Alkanesulfonic Acids. Cited 4 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY 4.0). Funded by: Research and Development Founder of ECNU.
Abstract (original language)
Background
Perfluorooctane sulfonate (PFOS), an industrially synthesized persistent organic pollutant (POP), is intricately intertwined with human production and daily life. It has been discovered that PFOS is related to an elevated incidence of birth defects in fetuses. In contrast, melatonin (MLT), a hormone secreted by the pineal gland, has been demonstrated to exert a protective effect on reproductive development.
Methods
This paper investigates the protective effect of MLT against PFOS‐induced reproductive toxicity by simultaneously orally administering MLT to pregnant mice exposed to PFOS. The therapeutic effect was evaluated through the monitoring of pregnancy outcomes, histological changes in the placenta, apoptosis and proliferation of placental spongiotrophoblast, as well as the expression of antioxidant enzyme genes, anti‐aging genes, anti‐inflammatory genes and other relevant genes.
Results
The results of the study demonstrated that MLT treatment reversed the adverse pregnancy outcomes caused by toxic PFOS, including a low number of implanted fetuses, low neonatal fetal weight, and an increased number of resorbed fetuses. MLT treatment decreased the levels of MDA, an oxidation product generated by PFOS in the placenta of pregnant mice, and increased the levels of the antioxidant enzyme SOD. Additionally, MLT was able to maintain the normalization of placental structure, reduce apoptosis and sustain the proliferation of placental spongiotrophoblast by upregulating the expression of antioxidant genes (Nrf2, CAT) and anti‐aging gene (Klotho), anti‐inflammatory gene (Hsd11b2), thereby counteracting the oxidative stress caused by PFOS in the placenta, moreover, it also reduced the expression of inflammatory genes (Pycard) in the placenta.
Conclusions
The findings firmly establish the effectiveness of MLT in mitigating the harmful impacts of tainted PFOS on reproductive development during pregnancy. This provides a novel therapeutic approach for addressing PFOS‐induced birth defects in fetuses.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Ecological Technology and Engineering, Shanghai Institute of Technology, Shanghai, China.
- School of Life Sciences, East China Normal University, Shanghai, China.
- Molecular Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
- Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
ORCID profiles: Honghui Han, Xueyun Ma
Funding
- Research and Development Founder of ECNU
Cite
APA
Han, J., Lu, Z., Qi, Y., Liu, T., Li, Y., Han, H., Zhao, C., & Ma, X. (2024). Melatonin Attenuates PFOS ‐Induced Reproductive Toxicity of Pregnant Mice due to Placental Damage Via Antioxidant, Anti‐Aging and Anti‐Inflammatory Pathways. Birth Defects Research. https://doi.org/10.1002/bdr2.2423
Vancouver
Han J, Lu Z, Qi Y, Liu T, Li Y, Han H, et al. Melatonin Attenuates PFOS ‐Induced Reproductive Toxicity of Pregnant Mice due to Placental Damage Via Antioxidant, Anti‐Aging and Anti‐Inflammatory Pathways. Birth Defects Research. 2024. doi:10.1002/bdr2.2423
BibTeX
@article{Han2024,
author = {Han, Jianqiu and Lu, Zhikai and Qi, Yalei and Liu, Tengfei and Li, Yongmei and Han, Honghui and Zhao, Chen and Ma, Xueyun},
title = {Melatonin Attenuates PFOS ‐Induced Reproductive Toxicity of Pregnant Mice due to Placental Damage Via Antioxidant, Anti‐Aging and Anti‐Inflammatory Pathways},
journal = {Birth Defects Research},
year = {2024},
doi = {10.1002/bdr2.2423}
}
EUVIMED